Clinical trial
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
NCT05313620 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- Lead sponsor
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- June 11, 2026
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thromboembolism, ulcerative colitis